HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NACDS New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

Reckitt doubles down with Mucinex

You may also be interested in...

Europe Continues To Drag On Reckitt Despite Boost From SSL

European sales continue to drag on Reckitt Benckiser even as newly acquired SSL brands contribute heavily to growth, the firm reports July 25.

Reckitt’s Revenues Soar On Strength Of Adams Brands, Product Innovations

Reckitt-Benckiser's revenues soared 13 percent in fiscal 2008 as health care and personal product sales grew more than twice as fast as its other segments - a trend the firm expects to continue despite private label competition and the global economic slump

SCOLR Ready To Answer FDA Questions On 12-Hour Pseudoephedrine ANDA

FDA has raised questions on "minor" issues regarding SCOLR Pharma's proposed nonprescription 12-hour pseudoephedrine tablet, according to the firm

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts